- Home
- TNGX vs KFS Comparison
TNGX vs KFS Comparison
Compare TNGX & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- KFS
- Stock Information
- Founded
- TNGX 2014
- KFS 1989
- Country
- TNGX United States
- KFS United States
- Employees
- TNGX N/A
- KFS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- KFS Property-Casualty Insurers
- Sector
- TNGX Health Care
- KFS Finance
- Exchange
- TNGX Nasdaq
- KFS Nasdaq
- Market Cap
- TNGX 248.2M
- KFS 338.1M
- IPO Year
- TNGX N/A
- KFS 1996
- Fundamental
- Price
- TNGX $2.49
- KFS $12.61
- Analyst Decision
- TNGX Strong Buy
- KFS
- Analyst Count
- TNGX 6
- KFS 0
- Target Price
- TNGX $12.20
- KFS N/A
- AVG Volume (30 Days)
- TNGX 3.5M
- KFS 56.3K
- Earning Date
- TNGX 05-12-2025
- KFS 05-08-2025
- Dividend Yield
- TNGX N/A
- KFS N/A
- EPS Growth
- TNGX N/A
- KFS N/A
- EPS
- TNGX N/A
- KFS N/A
- Revenue
- TNGX $40,990,000.00
- KFS $114,710,000.00
- Revenue This Year
- TNGX N/A
- KFS N/A
- Revenue Next Year
- TNGX N/A
- KFS N/A
- P/E Ratio
- TNGX N/A
- KFS N/A
- Revenue Growth
- TNGX 10.09
- KFS 6.75
- 52 Week Low
- TNGX $1.03
- KFS $7.06
- 52 Week High
- TNGX $12.02
- KFS $13.58
- Technical
- Relative Strength Index (RSI)
- TNGX 62.72
- KFS 87.34
- Support Level
- TNGX $1.93
- KFS $10.03
- Resistance Level
- TNGX $2.67
- KFS $13.58
- Average True Range (ATR)
- TNGX 0.39
- KFS 0.68
- MACD
- TNGX 0.07
- KFS 0.23
- Stochastic Oscillator
- TNGX 55.38
- KFS 88.27
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.